Medical Crossfire®: Expert Perspectives on c-Met and MET Targeting in NSCLC – Unveiling the Complexities of MET Dysregulation

Welcome and Introductions

Recognizing the Many Faces of MET Dysregulation in NSCLC

Current Strategies Targeting MET Dysregulation in NSCLC

Emerging Strategies Addressing MET Dysregulation in NSCLC: Targeting c-MET Overexpression in NSCLC

Emerging Strategies to Overcome Resistance for EGFR TKIs in NSCLC with c-MET overexpression and EGFR Mutations

What’s On the Radar: Data Reporting at the ASCO Annual Meeting and Clinical Trials on the Radar

Postsession Assessment and Closing Remarks